ELX-T2 20 mg ELIXIR product image ELIXIR product image
ELX-T2 30 mg ELIXIR product image ELIXIR product image

Research-use-only

ELX-T2

Mass / variant

Batch-specific documentation COA availability Secure checkout

Lab results

Lot documentation

ELIXIR provides applicable lot-specific laboratory documentation, including COAs, for products offered for sale.

No public COA record is currently displayed for this product selection. Use COA Lookup to search by lot number or product name.

Open COA lookup

All products listed on this site are for research purposes only. Not for human or animal use, diagnostic or therapeutic use, human dosing, injection, ingestion, consumption, administration, or application guidance.

Product Overview

ELX-T2 is a synthetic peptide analog supplied for research-use-only laboratory applications.

In research literature, this class of peptide analog is studied in incretin-receptor signaling contexts, including GIP and GLP-1 receptor systems, ligand-receptor interaction assays, and peptide pharmacology models.

Its research relevance centers on incretin-receptor assay systems, peptide-ligand characterization, and controlled studies of receptor-mediated peptide signaling.

Mass Options

  • 20 mgAvailable mass option
  • 30 mgAvailable mass option

Scientific Specifications

Molecular Formula
C225H348N48O68
Molecular Weight
4813
CAS Number
2023788-19-2
PubChem CID
166567236
Synonyms
Tirzepatide, Tirzepatide free base

Product FAQ

Where are COA and testing documents shown for this product?

Available COAs appear on the relevant product page and in COA Lookup. Search by lot number or product name to find records for a specific batch.

What does Research Use Only mean for this product?

All products listed on this site are for research purposes only. This product and related site information are not for human or animal use, diagnostic use, therapeutic use, human dosing, injection, ingestion, consumption, or administration.

Can ELIXIR provide use, dosing, or reconstitution instructions?

No. ELIXIR does not provide dosing, administration, reconstitution, human-use, animal-use, diagnostic, therapeutic, or application guidance.